Table 1 Patient characteristics
Intervention (n = 16) n [%] or median (IQR) | Control (n = 13) n [%] or median (IQR) | P* | |
|---|---|---|---|
Male sex | 8 [50%] | 10 [77%] | 0.249 |
Age in years | 61 (55–63) | 58 (49–63) | 0.538 |
Height in cm | 169 (165–173) | 174 (168–178) | 0.163 |
Weight in kg | 64 (58–71) | 69 (59–77) | 0.908 |
Body mass index in kg/m2 | 23 (18–30) | 23 (19–26) | 0.440 |
Pre-op. FSS-ICU | 35 (35–35) | 35 (34–35) | 0.999 |
Diagnosis subgroup | |||
Chronic obstructive pulmonary disease | 2 | 3 | 0.632 |
Interstitial lung disease, idiopathic pulmonary fibrosis | 13 | 8 | 0.406 |
Cystic fibrosis | 1 | 1 | 0.999 |
Primary pulmonary hypertension | 0 | 1 | 0.448 |
Co-morbidities | |||
Arterial hypertension | 6 | 3 | 0.454 |
Coronary heart disease | 3 | 3 | 0.999 |
Diabetes mellitus | 1 | 2 | 0.573 |
Chronic kidney disease | 1 | 1 | 0.999 |
SAPS II | 37 (32–42) | 32 (24–37) | 0.056 |
RASS (Day 1) | − 5 (− 5 to − 5) | − 5 (− 5 to − 5) | 0.217 |
SOFA (Day 1) | 7 (6–8) | 8 (7–8) | 0.671 |